Case-control study of association of eosinophilic gastrointestinal disorders with Helicobacter pylori infection in Japan

Journal of Clinical Biochemistry and Nutrition

Volumn 53, Issue 1, 2013, Pages 60-62

  Furuta, Kenji ^a   Adachi, Kyoichi ^a   Aimi, Masahito ^a   Ishimura, Norihisa ^a   Sato, Shuichi ^a   Ishihara, Shunji ^a   Kinoshita, Yoshikazu ^a  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

Eosinophilic esophagitis; Eosinophilic gastroenteritis; Helicobacter pylori infection; Th2

Indexed keywords

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EOSINOPHILIC ESOPHAGITIS; EOSINOPHILIC GASTROENTERITIS; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; JAPAN; MALE; MEDICAL EXAMINATION; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE;

EID: 84881280450     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.13-15     Document Type: Article

References (39)

1. Fujishiro H, Amano Y, Kushiyama Y, Ishihara S, Kinoshita Y. Eosinophilic esophagitis investigated by upper gastrointestinal endoscopy in Japanese patients. J Gastroenterol (in italic type) 2011;46:1142-1144.
2. Kinoshita Y, Furuta K, Ishimaura N, et al. Clinical characteristics of Japanese patients with eosinophilic esophagitis and eosinophilic gastroenteritis. J Gastroenterol 2012. DOI:10.1007/s00535-012-0640-x
3. Straumann A. Idiopathic eosinophilic gastrointestinal diseases in adults. Best Pract Res Clin Gastroenterol 2008;22:481-496.
4. Spergel JM, Book WM, Mays E, et al. Variation in prevalence, diagnostic criteria, and initial management options for eosinophilic gastrointestinal diseases in the United States. J Pediatr Gastroenterol Nutr 2011;52:300-306.
5. Spergel JM, Beausoleil JL, Mascarenhas M, Liacouras CA. The use of skin prick tests and patch tests to identify causative foods in eosinophilic esophagitis. J Allergy Clin Immunol 2002;109:363-368.
6. Liacouras CA. Eosinophilic esophagitis: treatment in 2005. Curr Opin Gastroenterol 2006;22:147-152.
7. Dunn BE, Cohen H, Blaser MJ. Helicobacter pylori. Clin Microbiol Rev 1997;10:720-741.
8. Asaka M, Kato M, Graham DY. Prevention of gastric cancer by Helicobacter pylori eradication. Intern Med 2010;49:633-636.
9. Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007;56:772-781.
10. Kawamura A, Adachi K, Takashima T, et al. Prevalence of functional dyspepsia and its relationship with Helicobacter pylori infection in a Japanese population. J Gastroenterol Hepatol 2001;16:384-388.
11. Fujisawa T, Kumagai T, Akamatsu T, Kiyosawa K, Matsunaga Y. Changes in seroepidemiological pattern of Helicobacter pylori and hepatitis A virus over the last 20 years in Japan. Am J Gastroenterol 1999;94:2094-2099.
12. Tamura T, Morita E, Kondo T, et al. Prevalence of Helicobacter pylori infection measured with urinary antibody in an urban area of Japan, 2008-2010. Nagoya J Med Sci 2012;74:63-70.
13. Takashima T, Iwakiri R, Sakata Y, et al. Endoscopic reflux esophagitis and Helicobacter pylori infection in young healthy Japanese volunteers. Digestion 2012;86:55-58.
14. D'Elios MM, Manghetti M, Almerigogna F, et al. Different cytokine profile and antigen-specificity repertoire in Helicobacter pylori-specific T cell clones from the antrum of chronic gastritis patients with or without peptic ulcer. Eur J Immunol 1997;27:1751-1755.
15. Amedei A, Cappon A, Codolo G, et al. The neutrophil-activating protein of Helicobacter pylori promotes Th1 immune responses. J Clin Invest 2006;116:1092-1101.
16. Taylor JM, Ziman ME, Huff JL, Moroski NM, Vajdy M, Solnick JV. Helicobacter pylori lipopolysaccharide promotes a Th1 type immune response in immunized mice. Vaccine 2006;24:4987-4994.
17. D'Elios MM, Andersen LP. Helicobacter pylori inflammation, immunity, and vaccines. Helicobacter 2007;12(Suppl 1):15-19.
18. Strachan DP. Hay fever, hygiene, and household size. BMJ 1989;299:1259-1260.
19. Martinez FD, Holt PG. Role of microbial burden in aetiology of allergy and asthma. Lancet 1999;354(Suppl 2):SII12-SII15.
20. Okada H, Kuhn C, Feillet H, Bach JF. The 'hygiene hypothesis' for autoimmune and allergic diseases: an update. Clin Exp Immunol 2010;160:1-9.
21. Dellon ES, Peery AF, Shaheen NJ, et al. Inverse association of esophageal eosinophilia with Helicobacter pylori based on analysis of a US pathology database. Gastroenterology 2011;141:1586-1592.
22. Kawaguchi Y, Mine T, Yasuzaki H, Kusakabe A, Kawana I, Umemura S. Eosinophilic gastroenteritis cured with Helicobacter pylori eradication. J Clin Gastroenterol 2008;42:1063-1064.
23. Kinoshita Y, Ishihara S, Amano Y, Fujishiro H. Diagnosis and treatment of eosinophilic esophagitis. Gastroenterological Endoscopy 2011;53:3-15.
24. Kinoshita Y, Ishihara S, Amano Y, Shimura S, Tada Y, Maruyama R. Diagnosis and treatment of eosinophilic gastroenteritis. Gastroenterological Endoscopy 2012;54:1797-1805.
25. Prasad GA, Alexander JA, Schleck CD, et al. Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota. Clin Gastroenterol Hepatol 2009;7:1055-1061.
26. Dellon ES, Gibbs WB, Fritchie KJ, et al. Clinical, endoscopic, and histologic findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2009;7:1305-1313.
27. Kapel RC, Miller JK, Torres C, Aksoy S, Lash R, Katzka DA. Eosinophilic esophagitis: a prevalent disease in the United States that affects all age groups. Gastroenterology 2008;134:1316-1321.
28. Sealock RJ, Rendon G, El-Serag HB. Systematic review: the epidemiology of eosinophilic oesophagitis in adults. Aliment Pharmacol Ther 2010;32:712-719.
29. Kinoshita Y, Furuta K, Ishimura N, Ishihara S. Elevated plasma cytokines in Japanese patients with eosinophilic esophagitis and gastroenteritis. Digestion 2012;86:238-243.
30. Zhu X, Wang M, Mavi P, et al. Interleukin-15 expression is increased in human eosinophilic esophagitis and mediates pathogenesis in mice. Gastroenterology 2010;139:182-193.
31. Blanchard C, Mingler MK, Vicario M, et al. IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids. J Allergy Clin Immunol 2007;120:1292-1300.
32. Zuo L, Fulkerson PC, Finkelman FD, et al. IL-13 induces esophageal remodeling and gene expression by an eosinophil-independent, IL-13R α2-inhibited pathway. J Immunol 2010;185:660-669.
33. Blanchard C, Stucke EM, Burwinkel K, et al. Coordinate interaction between IL-13 and epithelial differentiation cluster genes in eosinophilic esophagitis. J Immunol 2010;184:4033-4041.
34. Prescott SL, Macaubas C, Holt BJ, et al. Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T cell responses toward the Th2 cytokine profile. J Immunol 1998;160:4730-4737.
35. Barrios C, Brawand P, Berney M, Brandt C, Lambert PH, Siegrist CA. Neonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses: predominance of a Th2-biased pattern which persists after adult boosting. Eur J Immunol 1996;26:1489-1496.
36. Wills-Karp M, Santeliz J, Karp CL. The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat Rev Immunol 2001;1:69-75.
37. Haruma K. Influence of Helicobacter pylori on gastro-oesophageal reflux disease in Japan. Aliment Pharmacol Ther 2004;20:40-44.
38. Fixa B, Komárková O, Nozicka Z. Changing prevalence of some selected gastrointestinal diseases vis-à-vis H.pylori infection. Hepatogastroenterology 2011;58:1062-1066.
39. Chen Y, Blaser MJ. Inverse associations of Helicobacter pylori with asthma and allergy. Arch Intern Med 2007;167:821-827.